Alterity Therapeutics Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
  • Industry: Biotechnology
  • Company website

Company description

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Financial highlights

Market Capitalization$17.0793 million
P/E Ratio0
P/E Growth Ratio
Book Value0.009
Dividend Per Share0
Earnings Per Share-0.01
EBITDA-14,599.002
Profit Margin0
Operating Margin TTM-3.7218
Return on Assets TTM-0.2664
Return on Equity TTM-0.4738
Revenue TTM3,932.769

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
1998-06-30
1999-06-30
2000-06-30 78.758 421.933
2001-06-30 516.182 3,517.062
2002-06-30 794.39302 794.39302 5,789.93598
2003-06-30 1,811.08648 5,603.5607199999995
2004-06-30 2,307.12007 2,307.12007 11,196.8357
2005-06-30 2,642.33581 2,642.33581 14,449.653199999999
2006-06-30 762.48609 762.48609 12,175.82217
2007-06-30 507.04428 507.04428 11,497.47949
2008-06-30 491.99707 491.99707 13,225.816630000001
2009-06-30 428.193 428.193 8,716.689
2010-06-30 215.008 215.008 5,115.851
2011-06-30 162.92 162.92 6,436.179
2012-06-30 2,527.515 2,527.515 7,834.538
2013-06-30 150.867 4,488.526 7,640.241
2014-06-30 363.775 8,209.171 12,409.126
2015-06-30 176.842 257.299 176.842 10,612.383
2016-06-30 142.657 241.954 4,654.4 8,487.502
2017-06-30 132.396 241.892 2,913.177 6,772.367
2018-06-30 201.174 224.58 2,901.195 7,971.471
2019-06-30 108.538 322.097 108.538 12,473.335
2020-06-30 17.12 10,068.95
2021-06-30 20.68 14,738.692
2022-06-30 2.5 15,137.322
2023-06-30 16.44 14,353.178

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
1998-06-30 0.02 199.285 199.955 0.02
1999-06-30 0.02 1,836.945 1,917.615 0.02
2000-06-30 4,469.589 20,876.444 147.137 7,474.343
2001-06-30 6,854.873 22,287.46 894.583 12,276.892
2002-06-30 3,586.9257799999996 17,590.697940000002 912.81938 13,008.403900000001
2003-06-30 3,453.50123 16,341.277259999999 564.54144 16,691.33219
2004-06-30 29,400.62135 41,163.69246 2,696.3517599999996 49,204.61923
2005-06-30 21,366.15872 22,198.618019999998 2,684.03562 55,180.64428
2006-06-30 10,019.86465 10,427.480619999998 1,692.82499 42.40421 55,131.16654
2007-06-30 7,407.71477 7,720.57893 2,109.55169 45.62612
2008-06-30 11,243.12643 11,723.433869999999 1,835.92077
2009-06-30 4,304.977 4,597.25 847.434
2010-06-30 5,227.298 6,801.417 1,572.101
2011-06-30 8,838.245 9,010.952 2,079.75 285.785
2012-06-30 5,636.469 7,341.868 1,718.421 299.012
2013-06-30 13,346.76 17,073.821 3,099.108 802.641 101,379.111
2014-06-30 34,167.018 41,640.855 3,954.568 140,009.415
2015-06-30 34,909.574 41,834.382 2,721.118 152.603 146,895.714
2016-06-30 28,593.538 33,725.02 2,357.807 146,879.214
2017-06-30 21,884.957 25,280.946 1,590.912 43.988 144,018.006
2018-06-30 15,235.556 18,726.013 2,644.856 9.514 143,910.328
2019-06-30 14,399.904 19,909.918 3,355.145 0 156,632.636
2020-06-30 9,196.892 13,304.834 2,756.904 32.879 160,703.754
2021-06-30 28,115.516 33,585.754 3,115.294 27.746 197,447.99
2022-06-30 34,806.799 41,362.611 5,894.02 57.632 213,787.061
2023-06-30 15,773.783 27,317.636 4,504.727 107.177 213,971.323

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2002-06-30 -5,451.372719999999 -3,767.9827200000004 -3,271.60409 6,858.52987 3,586.9257799999996
2003-06-30 -4,571.22911 -3,579.95568 -120.87119 3,574.37242 3,453.50123
2004-06-30 -9,825.533140000001 -5,314.9204 25,957.8895 3,442.73185 29,400.62135
2005-06-30 -24,907.010449999998 -11,372.429310000001 -8,094.08079 29,460.2395 21,366.15872
2006-06-30 -11,726.43267 -11,658.29701 -11,446.47944 21,466.34409 10,019.86465
2007-06-30 -11,140.001970000001 -9,197.836449999999 -2,603.98067 10,011.69544 7,407.71477
2008-06-30 -13,589.79743 -9,411.556859999999 3,817.95981 7,425.16661 11,243.12643
2009-06-30 -7,522.789 -6,994.174 -6,914.058 11,219.035 4,304.977
2010-06-30 -4,906.922 -4,708.939 922.321 4,304.977 5,227.298
2011-06-30 -6,431.185 -4,558.415 3,610.947 5,227.298 8,838.245
2012-06-30 -5,239.469 -6,845.906 -3,201.776 8,838.245 5,636.469
2013-06-30 -7,787.242 -7,951.254 7,710.291 5,636.469 13,346.76
2014-06-30 -13,329.239 -13,536.223 20,820.258 13,346.76 34,167.018
2015-06-30 -5,885.069 -10,871.074 742.556 34,167.018 34,909.574
2016-06-30 -7,729.551 -7,418.526 -6,316.036 34,909.574 28,593.538
2017-06-30 -7,542.076 -5,865.08 -6,708.581 28,593.538 21,884.957
2018-06-30 -8,265.737 -6,245.188 -6,649.401 21,884.957 15,235.556
2019-06-30 -12,337.83 -13,954.818 -835.652 15,235.556 14,399.904
2020-06-30 -10,059.684 -9,431.122 -5,203.012 14,399.904 9,196.892 0
2021-06-30 -15,309.353 -17,330.069 18,919 9,197 28,116 0
2022-06-30 -12,847.061 -12,337.274 6,691 28,116 34,807 0
2023-06-30 -13,806.515 -20,065 -19,034 34,807 15,773 0